Robert J. Cardnell

3.2k total citations
27 papers, 572 citations indexed

About

Robert J. Cardnell is a scholar working on Oncology, Molecular Biology and Epidemiology. According to data from OpenAlex, Robert J. Cardnell has authored 27 papers receiving a total of 572 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 10 papers in Molecular Biology and 8 papers in Epidemiology. Recurrent topics in Robert J. Cardnell's work include Lung Cancer Research Studies (16 papers), Neuroendocrine Tumor Research Advances (7 papers) and Pancreatic and Hepatic Oncology Research (5 papers). Robert J. Cardnell is often cited by papers focused on Lung Cancer Research Studies (16 papers), Neuroendocrine Tumor Research Advances (7 papers) and Pancreatic and Hepatic Oncology Research (5 papers). Robert J. Cardnell collaborates with scholars based in United States, Singapore and United Kingdom. Robert J. Cardnell's co-authors include Lauren A. Byers, Jing Wang, Ross B. Mikkelsen, John V. Heymach, Lixia Diao, C. Allison Stewart, Carl M. Gay, Kavya Ramkumar, Li Shen and You-Hong Fan and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Robert J. Cardnell

26 papers receiving 567 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert J. Cardnell United States	15	378	290	164	86	77	27	572
Olaf Klingbeil United States	12	316 0.8×	425 1.5×	152 0.9×	62 0.7×	70 0.9×	17	685
Lingyu Li China	15	369 1.0×	273 0.9×	64 0.4×	190 2.2×	141 1.8×	35	785
Julien Bollard France	8	217 0.6×	241 0.8×	92 0.6×	31 0.4×	120 1.6×	16	457
Divis Khaira United States	8	393 1.0×	378 1.3×	88 0.5×	239 2.8×	101 1.3×	8	784
Sheung-Tat Fan Hong Kong	10	204 0.5×	219 0.8×	183 1.1×	222 2.6×	106 1.4×	10	688
Moacyr Oliveira United States	4	237 0.6×	392 1.4×	40 0.2×	64 0.7×	83 1.1×	4	593
Fumiaki Ozawa Japan	11	316 0.8×	267 0.9×	81 0.5×	35 0.4×	118 1.5×	26	605
Cathy E. Nolan United States	6	206 0.5×	384 1.3×	41 0.3×	68 0.8×	61 0.8×	8	585
Fawaz Halwani Canada	11	195 0.5×	260 0.9×	46 0.3×	65 0.8×	35 0.5×	16	522
Tadashi Hayasaka Japan	8	185 0.5×	287 1.0×	84 0.5×	56 0.7×	29 0.4×	16	511

Countries citing papers authored by Robert J. Cardnell

Since Specialization

Citations

This map shows the geographic impact of Robert J. Cardnell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert J. Cardnell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert J. Cardnell more than expected).

Fields of papers citing papers by Robert J. Cardnell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert J. Cardnell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert J. Cardnell. The network helps show where Robert J. Cardnell may publish in the future.

Co-authorship network of co-authors of Robert J. Cardnell

This figure shows the co-authorship network connecting the top 25 collaborators of Robert J. Cardnell. A scholar is included among the top collaborators of Robert J. Cardnell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert J. Cardnell. Robert J. Cardnell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Xie, Mingchao, Siyu Liu, Andrew G. Chambers, et al.. (2025). Multi-omic profiling provides insights into the heterogeneity, microenvironmental features, and biomarker landscape of small-cell lung cancer. Molecular Cancer. 25(1). 6–6.

Ramkumar, Kavya, Azusa Tanimoto, Carminia M. Della Corte, et al.. (2023). Targeting BCL2 Overcomes Resistance and Augments Response to Aurora Kinase B Inhibition by AZD2811 in Small Cell Lung Cancer. Clinical Cancer Research. 29(16). 3237–3249. 14 indexed citations

Zhang, Bingnan, Yan Yang, C. Allison Stewart, et al.. (2023). Abstract 3196: Subtype-specific targeting of cell surfaceome with CAR T therapies in small cell lung cancer. Cancer Research. 83(7_Supplement). 3196–3196. 1 indexed citations

Konen, Jessica, B. Leticia Rodriguez, Joshua K. Ochieng, et al.. (2021). Dual Inhibition of MEK and AXL Targets Tumor Cell Heterogeneity and Prevents Resistant Outgrowth Mediated by the Epithelial-to-Mesenchymal Transition in NSCLC. Cancer Research. 81(5). 1398–1412. 24 indexed citations

Kundu, Kiran, Robert J. Cardnell, Bingnan Zhang, et al.. (2021). SLFN11 biomarker status predicts response to lurbinectedin as a single agent and in combination with ATR inhibition in small cell lung cancer. Translational Lung Cancer Research. 10(11). 4095–4105. 29 indexed citations

Ramkumar, Kavya, C. Allison Stewart, Kasey R. Cargill, et al.. (2020). AXL Inhibition Induces DNA Damage and Replication Stress in Non–Small Cell Lung Cancer Cells and Promotes Sensitivity to ATR Inhibitors. Molecular Cancer Research. 19(3). 485–497. 38 indexed citations

Stewart, C. Allison, Carl M. Gay, Kavya Ramkumar, et al.. (2020). 1735P SARS-CoV-2 infection induces EMT-like molecular changes, including ZEB1-mediated repression of the viral receptor ACE2, in lung cancer models. Annals of Oncology. 31. S1015–S1015. 10 indexed citations

Hillman, R. Tyler, Robert J. Cardnell, Junya Fujimoto, et al.. (2020). Comparative genomics of high grade neuroendocrine carcinoma of the cervix. PLoS ONE. 15(6). e0234505–e0234505. 28 indexed citations

Cargill, Kasey R., Carl M. Gay, Robert J. Cardnell, et al.. (2020). Abstract 232: Comprehensive metabolic profiling and vulnerabilities to metabolic inhibitors among small cell lung cancer subtypes. Cancer Research. 80(16_Supplement). 232–232. 1 indexed citations

10.

Gay, Carl M., Lixia Diao, C. Allison Stewart, et al.. (2019). OA03.06 ASCL1, NEUROD1, and POU2F3 Drive Distinct Subtypes of Small Cell Lung Cancer with Unique Therapeutic Vulnerabilities. Journal of Thoracic Oncology. 14(10). S213–S213. 4 indexed citations

11.

Sen, Triparna, Carminia Maria Della Corte, Snezana Milutinovic, et al.. (2019). Combination Treatment of the Oral CHK1 Inhibitor, SRA737, and Low-Dose Gemcitabine Enhances the Effect of Programmed Death Ligand 1 Blockade by Modulating the Immune Microenvironment in SCLC. Journal of Thoracic Oncology. 14(12). 2152–2163. 91 indexed citations

12.

Ramkumar, Kavya, Carminia Maria Della Corte, Lixia Diao, et al.. (2019). Abstract B024: Clinical, genomic, and immune landscape of the receptor tyrosine kinase AXL in non-small cell lung cancer. Molecular Cancer Therapeutics. 18(12_Supplement). B024–B024. 1 indexed citations

13.

Hillman, R. Tyler, Robert J. Cardnell, Junya Fujimoto, et al.. (2018). Genomic landscape of small cell neuroendocrine cervical cancer. Gynecologic Oncology. 149(3). 626–627. 1 indexed citations

14.

Cardnell, Robert J., Ying Feng, Lixia Diao, et al.. (2016). Activation of the PI3K/mTOR Pathway following PARP Inhibition in Small Cell Lung Cancer. PLoS ONE. 11(4). e0152584–e0152584. 65 indexed citations

15.

Sundaresan, Gobalakrishnan, Robert J. Cardnell, Vasily A. Yakovlev, et al.. (2015). The Role of Nitric Oxide Synthase Uncoupling in Tumor Progression. Molecular Cancer Research. 13(6). 1034–1043. 53 indexed citations

16.

Cardnell, Robert J., Carmen Behrens, Lixia Diao, et al.. (2015). An Integrated Molecular Analysis of Lung Adenocarcinomas Identifies Potential Therapeutic Targets among TTF1-Negative Tumors, Including DNA Repair Proteins and Nrf2. Clinical Cancer Research. 21(15). 3480–3491. 37 indexed citations

17.

Mukhopadhyay, Nitai D., Yi Ning, Robert J. Cardnell, et al.. (2015). A Preliminary Study on Racial Differences in HMOX1, NFE2L2, and TGFβ1 Gene Polymorphisms and Radiation-Induced Late Normal Tissue Toxicity. International Journal of Radiation Oncology*Biology*Physics. 93(2). 436–443. 15 indexed citations

18.

Cardnell, Robert J., Gracious R. Ross, Chunqing Guo, et al.. (2013). Sepiapterin Ameliorates Chemically Induced Murine Colitis and Azoxymethane-Induced Colon Cancer. Journal of Pharmacology and Experimental Therapeutics. 347(1). 117–125. 16 indexed citations

19.

Mezzaroma, Eleonora, Stefano Toldo, Robert J. Cardnell, et al.. (2012). Abstract 17799: Role Of Interleukin-1 In Acute Radiation-induced Cardiomyopathy. Circulation. 126. 1 indexed citations

20.

Cardnell, Robert J. & Ross B. Mikkelsen. (2011). Nitric Oxide Synthase Inhibition Enhances the Antitumor Effect of Radiation in the Treatment of Squamous Carcinoma Xenografts. PLoS ONE. 6(5). e20147–e20147. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact